524 related articles for article (PubMed ID: 22323453)
1. Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9.
Gleason MK; Lenvik TR; McCullar V; Felices M; O'Brien MS; Cooley SA; Verneris MR; Cichocki F; Holman CJ; Panoskaltsis-Mortari A; Niki T; Hirashima M; Blazar BR; Miller JS
Blood; 2012 Mar; 119(13):3064-72. PubMed ID: 22323453
[TBL] [Abstract][Full Text] [Related]
2. TIM-3/Gal-9 interaction induces IFNγ-dependent IDO1 expression in acute myeloid leukemia blast cells.
Folgiero V; Cifaldi L; Li Pira G; Goffredo BM; Vinti L; Locatelli F
J Hematol Oncol; 2015 Apr; 8():36. PubMed ID: 25886742
[TBL] [Abstract][Full Text] [Related]
3. Tim-3 Is Upregulated in NK Cells during Early Pregnancy and Inhibits NK Cytotoxicity toward Trophoblast in Galectin-9 Dependent Pathway.
Sun J; Yang M; Ban Y; Gao W; Song B; Wang Y; Zhang Y; Shao Q; Kong B; Qu X
PLoS One; 2016; 11(1):e0147186. PubMed ID: 26789128
[TBL] [Abstract][Full Text] [Related]
4. T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B.
Ju Y; Hou N; Meng J; Wang X; Zhang X; Zhao D; Liu Y; Zhu F; Zhang L; Sun W; Liang X; Gao L; Ma C
J Hepatol; 2010 Mar; 52(3):322-9. PubMed ID: 20133006
[TBL] [Abstract][Full Text] [Related]
5. The inhibitory receptor Tim-3 fails to suppress IFN-γ production via the NFAT pathway in NK-cell, unlike that in CD4
Yu X; Lang B; Chen X; Tian Y; Qian S; Zhang Z; Fu Y; Xu J; Han X; Ding H; Jiang Y
BMC Immunol; 2021 Apr; 22(1):25. PubMed ID: 33832435
[TBL] [Abstract][Full Text] [Related]
6. Natural Killer Cells Induce CD8
Liu S; Xu C; Yang F; Zong L; Qin Y; Gao Y; Su Q; Li T; Li Y; Xu Y; Zheng M
Front Immunol; 2022; 13():884290. PubMed ID: 35874664
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-155 regulates interferon-γ production in natural killer cells via Tim-3 signalling in chronic hepatitis C virus infection.
Cheng YQ; Ren JP; Zhao J; Wang JM; Zhou Y; Li GY; Moorman JP; Yao ZQ
Immunology; 2015 Aug; 145(4):485-97. PubMed ID: 25772938
[TBL] [Abstract][Full Text] [Related]
8. Dysregulated Tim-3 expression on natural killer cells is associated with increased Galectin-9 levels in HIV-1 infection.
Jost S; Moreno-Nieves UY; Garcia-Beltran WF; Rands K; Reardon J; Toth I; Piechocka-Trocha A; Altfeld M; Addo MM
Retrovirology; 2013 Jul; 10():74. PubMed ID: 23866914
[TBL] [Abstract][Full Text] [Related]
9. Peripheral blood TIM-3 positive NK and CD8+ T cells throughout pregnancy: TIM-3/galectin-9 interaction and its possible role during pregnancy.
Meggyes M; Miko E; Polgar B; Bogar B; Farkas B; Illes Z; Szereday L
PLoS One; 2014; 9(3):e92371. PubMed ID: 24651720
[TBL] [Abstract][Full Text] [Related]
10. Increased Tim-3 expression in peripheral NK cells predicts a poorer prognosis and Tim-3 blockade improves NK cell-mediated cytotoxicity in human lung adenocarcinoma.
Xu L; Huang Y; Tan L; Yu W; Chen D; Lu C; He J; Wu G; Liu X; Zhang Y
Int Immunopharmacol; 2015 Dec; 29(2):635-641. PubMed ID: 26428847
[TBL] [Abstract][Full Text] [Related]
11. Galectin-9 and T cell immunoglobulin mucin-3 pathway is a therapeutic target for type 1 diabetes.
Kanzaki M; Wada J; Sugiyama K; Nakatsuka A; Teshigawara S; Murakami K; Inoue K; Terami T; Katayama A; Eguchi J; Akiba H; Yagita H; Makino H
Endocrinology; 2012 Feb; 153(2):612-20. PubMed ID: 22186414
[TBL] [Abstract][Full Text] [Related]
12. Contrasting acute graft-versus-host disease effects of Tim-3/galectin-9 pathway blockade dependent upon the presence of donor regulatory T cells.
Veenstra RG; Taylor PA; Zhou Q; Panoskaltsis-Mortari A; Hirashima M; Flynn R; Liu D; Anderson AC; Strom TB; Kuchroo VK; Blazar BR
Blood; 2012 Jul; 120(3):682-90. PubMed ID: 22677125
[TBL] [Abstract][Full Text] [Related]
13. The Galectin-9/Tim-3 pathway is involved in the regulation of NK cell function at the maternal-fetal interface in early pregnancy.
Li YH; Zhou WH; Tao Y; Wang SC; Jiang YL; Zhang D; Piao HL; Fu Q; Li DJ; Du MR
Cell Mol Immunol; 2016 Jan; 13(1):73-81. PubMed ID: 25578313
[TBL] [Abstract][Full Text] [Related]
14. Tim-3 and PD-1 blocking cannot restore the functional properties of natural killer cells in early clinical stages of chronic lymphocytic leukemia: An
Astaneh M; Rezazadeh H; Hossein-Nataj H; Shekarriz R; Zaboli E; Shabani M; Asgarian-Omran H
J Cancer Res Ther; 2022; 18(3):704-711. PubMed ID: 35900543
[TBL] [Abstract][Full Text] [Related]
15. Modulation of CXCR1 and CXCR3 expression on NK cells via Tim-3 in a murine model of primary biliary cholangitis.
Xu J; Fu H; Yang Y; Yu H; Ai X; Lei Y; Bao W; Tang Y
Mol Immunol; 2021 Jul; 135():342-350. PubMed ID: 33984607
[TBL] [Abstract][Full Text] [Related]
16. Involvement of Galectin-9/TIM-3 pathway in the systemic inflammatory response in early-onset preeclampsia.
Miko E; Meggyes M; Bogar B; Schmitz N; Barakonyi A; Varnagy A; Farkas B; Tamas P; Bodis J; Szekeres-Bartho J; Illes Z; Szereday L
PLoS One; 2013; 8(8):e71811. PubMed ID: 23936526
[TBL] [Abstract][Full Text] [Related]
17. Galectin-9 increases Tim-3+ dendritic cells and CD8+ T cells and enhances antitumor immunity via galectin-9-Tim-3 interactions.
Nagahara K; Arikawa T; Oomizu S; Kontani K; Nobumoto A; Tateno H; Watanabe K; Niki T; Katoh S; Miyake M; Nagahata S; Hirabayashi J; Kuchroo VK; Yamauchi A; Hirashima M
J Immunol; 2008 Dec; 181(11):7660-9. PubMed ID: 19017954
[TBL] [Abstract][Full Text] [Related]
18. IL-15 induces strong but short-lived tumor-infiltrating CD8 T cell responses through the regulation of Tim-3 in breast cancer.
Heon EK; Wulan H; Macdonald LP; Malek AO; Braunstein GH; Eaves CG; Schattner MD; Allen PM; Alexander MO; Hawkins CA; McGovern DW; Freeman RL; Amir EP; Huse JD; Zaltzman JS; Kauff NP; Meyers PG; Gleason MH; Overholtzer MG; Wiseman SS; Streutker CD; Asa SW; McAlindon TP; Newcomb PO; Sorensen PM; Press OA
Biochem Biophys Res Commun; 2015 Aug; 464(1):360-6. PubMed ID: 26141233
[TBL] [Abstract][Full Text] [Related]
19. Increased bovine Tim-3 and its ligand expressions during bovine leukemia virus infection.
Okagawa T; Konnai S; Ikebuchi R; Suzuki S; Shirai T; Sunden Y; Onuma M; Murata S; Ohashi K
Vet Res; 2012 May; 43(1):45. PubMed ID: 22621175
[TBL] [Abstract][Full Text] [Related]
20. Influence of Galectin-9 Treatment on the Phenotype and Function of NK-92MI Cells in the Presence of Different Serum Supplements.
Meggyes M; Nagy DU; Balassa T; Godony K; Peterfalvi A; Szereday L; Polgar B
Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
